Methods and results
We retrospectively enrolled 1388 adults with DM1 referred to six French medical centres between January 2000 and October 2013. We confirmed their vital status, classified all deaths, and determined the incidence of major conduction defects requiring permanent pacing and sustained VTA. We searched for predictors of overall survival, SD, major conduction defects, and sustained VTA by Cox regression analysis. Over a median 10-year follow-up, 253 (18.2%) patients died, 39 (3.6%) suddenly. Analysis of the cardiac rhythm at the time of the 39 SD revealed sustained VTA in 9, asystole in 5, complete atrioventricular block in 1 and electromechanical dissociation in two patients. Non-cardiac causes were identified in the five patients with SD who underwent autopsies. Major conduction defects developed in 143 (19.3%) and sustained VTA in 26 (2.3%) patients. By Cox regression analysis, age, family history of SD and left bundle branch block were independent predictors of SD, while age, male sex, electrocardiographic conduction abnormalities, syncope, and atrial fibrillation were independent predictors of major conduction defects; non-sustained VTA was the only predictor of sustained VTA.
.. Conclusions
SD was a frequent mode of death in DM1, with multiple mechanisms involved. Major conduction defects were by far more frequent than sustained VTA, whose only independent predictor was a personal history of non-sustained VTA. ClinicalTrials.gov no: NCT01136330.
Introduction
With a 1:8000 incidence, myotonic dystrophy type 1 (DM1), also known as Steinert's disease, is the most common neuromuscular disease in adults. 1 It is an autosomal, dominant disorder caused by the expansion of a (CTG)n triplet repeat in the untranslated 3 0 region of the DMPK gene. 2 The manifestations of the disease include muscle weakness, myotonia, multiple endocrine disorders, respiratory insufficiency, conduction system disease, ventricular dysfunction, and supraventricular and ventricular arrhythmias. 3, 4 The prevention of sudden death (SD), striking up to 1/3 of patients with DM1, is central in the management of the disease. [5] [6] [7] Because the largest proportion of SD is attributed to the progression of conduction system disease to complete atrioventricular (AV) block, the practice guidelines issued by the European Society of Cardiology (ESC) recommend the implantation of a permanent pacemaker for the prevention of SD in DM1 patients with any degree of AV block on the surface electrocardiogram (ECG). 8 However, the clinical benefit conferred by this strategy, which has been assigned a class IIb recommendation, and the most appropriate criteria to select candidates for permanent pacing are still debated. 9 Besides, the contribution of ventricular tachyarrhythmias (VTA) to a proportion of SD, particularly in pacemaker recipients, has raised the issue of a potential primary preventive benefit conferred by implantable cardioverter defibrillators (ICD). [10] [11] [12] A better understanding of the underlying mechanisms of SD in DM1 and an improvement of the prediction of major conduction defects and sustained VTA appear critical, particularly to optimize the potential benefit of SD preventive strategies. We designed this multicentre study in patients with DM1 to (1) measure the incidence of SD and describe the role of VTA and other causes, (2) measure the incidence of major conduction defects and sustained VTA, and (3) identify predictors of SD, sustained VTA and major conduction defects.
Methods

Registry design and enrolment criteria
We retrospectively included in our study the 1388 consecutive patients, > _18 years of age, who had been admitted to the cardiology and neurology departments of six French university hospitals for management of DM1, between January 2000 and October 2013. The disease was diagnosed in all patients by the presence of > _50 CTG triplets in the 3 0 untranslated region of the DMPK gene on blood leukocytes. In France, the genetic tests and patient follow-up for DM1 are performed in reference centres for muscular diseases, dedicated to the management of neuromuscular diseases. Therefore, nearly all patients in whom DM1 was diagnosed during the study period in the catchment areas of the six participating hospitals were included in our registry.
The patients were followed at 6-month intervals and examined by a cardiologist in the ambulatory department of the participating medical centres. Pacemaker recipients underwent systematic interrogations of their devices' memories. Their medical records were reviewed and the results of genetic, neurological, and cardiac investigations, including arrhythmic events stored in the pacemakers' memories, were entered in our database. The vital status of patients who were not seen after October 2013, and whose circumstances or cause of death were unknown, was ascertained by consulting the National Death Registry or by contacting their primary physician.
This study, which is in compliance with the ethical principles formulated in the declaration of Helsinki, was approved by our local Ethics Committees. All patients, except those who had died before the initiation of the study, granted their informed, written consent to participate in the study. 
Study endpoints
Our objective was to describe the incidence and identify predictors of SD, major conduction defects and sustained VTA in DM1. The circumstances of all deaths, sustained VTA, and major conduction defects were reviewed by two cardiologists (AL & HMB) unaware of the patients' medical history and clinical status. Death was classified as sudden if it occurred unexpectedly (a) within 1 h of onset of cardiac manifestations, in absence of prior hemodynamic deterioration, (b) during sleep, or (c) within 24 h after the patient was last seen alive and apparently stable clinically. 13 A VTA was classified as sustained if it lasted >30 s, or if it was haemodynamically unstable and required immediate termination by a DC shock. We classified sustained VTA as ventricular tachycardia or fibrillation based on the analysis of the cardiac rhythm during cardiopulmonary reanimation, or stored in the pacemaker memories, or both. A sustained VTA stored in the pacemaker memory was classified as ventricular tachycardia when the ventricular rhythm was regular, and as a ventricular fibrillation when the rhythm was irregular and the rate >200 bpm. Major conduction defects were 3rd degree AV block, type II 2nd degree AV block, or sinus node dysfunction requiring permanent pacing. In patients with pacing devices, a specific diagnostic algorithm was downloaded to the randomaccess memory, allowing the diagnosis of major conduction defects at the ventricular level during the VDI mode (ventricular pacing and sensing plus atrial sensing). 14 
Statistical analyses
Categorical data are reported as counts, percentages and quantitative data as means and standard deviations (SD) or medians and interquartile ranges [IQR] . Overall survival was estimated, using the Kaplan-Meier product-limit method, and the cumulative incidence of death from various causes, SD in particular, was estimated in competing risks framework using the usual estimator. 15 Factors associated with overall survival were analysed, using a multiple variable Cox model, with follow-up censored at 12 years. Model discrimination was assessed by the c-index. 16, 17 Factors associated with SD, sustained VTA and major conduction defects were analysed, using a cause-specific Cox proportional hazards model, 18 also in a competing risks framework. SD and sustained VTA were analysed in the subset of patients who had no history of sustained VTA. Hazard ratios (HR) were calculated. Factors associated with conduction defects were examined in the subgroup of patients who had no history of sustained VTA or major conduction defects. Given the limited number of SD and sustained VTA, the multiple variable models were limited to variables emerging with a P value < 0.20 in the single variable analysis of risk of event. The proportional hazards assumption was verified by examination of Schoenfeld residuals and Grambsch-Therneau lack-of-fit test. 19 Missing baseline data were handled through multiple imputations by chained equations, using the baseline hazard of death and cause-specific hazards of other endpoints in the imputation model. 20, 21 Since predictors were absent in approximately 20% of patients, we created and analysed separately 20 independent imputed data sets. 22 The estimates were then 23 
Results
Study population
The 1388 patients (52.5% women) included in this analysis were 40 ± 13 years of age. Their baseline characteristics are shown in Table 1 . Histories of sustained VTA were elicited in 11 and major conduction defects in 27 patients. A type 1 Brugada pattern was present on the ECG of eight patients. The median duration of followup was 10.3 years [6.7-13.0]. Among the 1388 study participants, 49 (3.5%) were lost to follow-up, including 24 deaths found in our review of the national indexes. Figure 1 shows the outcomes of the 1,388 patients screened between years 2000 and 2013.
Permanent pacemakers were implanted during the referral period in 328 patients (23.6%; 52.1% women), at the mean age of 44 ± 12 years. The indications for permanent pacing included (1) 3rd degree or type II 2nd degree AV block, or sinus node dysfunction (ACC/ AHA class I indications) in 63 patients, and (2) 1st degree AV or fascicular block on the surface ECG, a HV interval >70 ms, or both (ACC/AHA class IIb indications) in 265 patients.
Overall survival and incidence, mechanisms, and causes of sudden death During follow-up, 253 of the 1388 patients (18.2%) died, 39 (15.4%) suddenly (Figure 1) . The median age at the time of death was 56.2 years. The overall survival and cumulative incidence of SD are presented in Figure 2 and Table 2 . The non-sudden deaths were caused by progressive neuromuscular respiratory failure in 97 (38.3%), miscellaneous disorders in 103 (40.7%) and undetermined causes in 14 (5.5%) patients. The classifications of SD based on autopsies or on analyses of the cardiac rhythm are shown in Figure 1 . Among the five patients who underwent an autopsy, four suffered massive pulmonary embolisms and one suffered a laryngeal occlusion. Among the 17 patients whose cardiac rhythm was analysable (8 whose pacemaker memories were interrogated post mortem and 9 whose rhythm observed at the time of collapse was described in the cardiopulmonary reanimation report), nine had developed a sustained VTA, five died in asystole, one in 3rd degree AV block, and two had developed electromechanical dissociation.
Sustained ventricular tachyarrhythmias
Sustained VTA developed during follow-up in 26 patients (62% men), at a median age of 46.0 [38.5-53.8] years, representing a 2.3% cumulative incidence at 12 years. Their clinical characteristics are shown in Table 2 and in Supplementary material online, Table S3 . The initial VTA were ventricular tachycardia in 18 and ventricular fibrillation in eight patients. A personal history of sustained VTA was elicited before or at the time of entry into the study in six of these 26 patients, of whom two underwent implantation of an ICD, and five had asymptomatic, non-sustained VT recorded during 24-h ambulatory ECG or stored in the device memories. Six of the patients who developed VTA had left ventricular (LV) ejection fractions (EF) < _35% and 8 had LVEF < _ 50%. A type 1 Brugada pattern was present on the ECG of three patients.
Major conduction defects
Major conduction defects developed in 143 patients (56.6% men), at a median age of 50.0 years [41. 5-56.5 ], representing a 19.3% cumulative incidence at 12 years. Third-degree AV block developed in 99 (69.2%), 2nd degree type II AV block in 32 (22.3%), and sinus node dysfunction in 12 (13.2%) patients, whose clinical characteristics are shown in Table  2 . Asymptomatic conduction defects were recorded during 24-h ambulatory ECG or were stored in the memories of implanted devices in 80 of these 143 patients (55.9%) (no loop recorder was implanted), while 63 patients (44.0%) developed symptomatic conduction defects, including 52 patients who suffered a syncopal episode.
Predictors of death, sudden death, sustained ventricular tachyarrhythmias, and major conduction defects
The results of the single and multiple variable analyses of the relationship between the baseline patient characteristics and the clinical outcomes are shown in Supplementary material online, Table S4 and in  Table 3 , respectively, and that of the relationship between baseline characteristics and 3rd or 2nd degree AV block in Supplementary material online, Table S5 .
By single variable analysis, (1) male sex, atrial fibrillation (AF), syncope, heart rate, PR and QRS intervals, 1st degree AV block, left bundle branch block (BBB), right BBB, and LVEF <50% were associated with overall survival, (2) age, family history of SD, non-sustained VT, AF, PR, and QRS intervals, 1st degree AV block, and left BBB were associated with SD, (3) coronary artery disease, AF, non-sustained VT, QRS interval, left and right BBB, and LVEF <50% were associated with sustained VTA, and (4) age, male sex, AF, LVEF <50%, and any conduction defect on the ECG were associated with major conduction defects.
By multiple variable analysis, age, male sex, syncope, heart rate, and 1st degree AV block were independent predictors of death from any cause. Age, a family history of SD and left BBB were significantly associated with SD. Non-sustained VTA was the only predictor of sustained VTA. Age, male sex, AF, syncope, and any conduction defect on the ECG were independent predictors of major conduction defects. The values of the C-index for the four models presented were 0.774, 0.749, 0.740, and 0.782, respectively.
Discussion
We observed, in our overall sample, a 3.6% cumulative incidence of SD over a median 10-year follow up, with multiple mechanisms involved, including conduction defects, sustained VTA, and noncardiac causes. Age, left BBB, and family history of SD are independent predictors of SD we identified. Major conduction defects developed in 19 .3% of patients and were independently associated with conduction defects on the ECG, a personal history of syncope, or AF. The only independent predictor of sustained VTA, which occurred in 2.3% of patients, was a personal history of non-sustained VTA.
Our study provides new information regarding the risk of SD in patients with DM1. In the studies by Groh et al. 10 and by Breton et al., 24 each including over 400 patients presenting with DM1, a PR interval > _200 or > _240 ms, a QRS complex > _120 ms, or both, were independent predictors of SD. We found that, as opposed to left BBB, 1st degree AV block and right BBB were not independent predictors of SD by multiple variable analysis. However, 1st degree AV block, left BBB and right BBB were all independently associated with the development of major conduction defects. Our observations and those made in earlier studies, suggest that patients who suffer from DM1 and whose ECG reveal the presence of conduction abnormalities, are at an increased risk of SD, major conduction defects, or both, and that left BBB represents the ECG abnormality associated with probably the highest risk of SD. In contrast to the report by Groh et al., 10 AF was not significantly associated with SD in our multiple variable analysis. The high incidence of major conduction defects, consisting mainly of complete AV block, which developed in approximately 20% of our total sample and 40% of pacemaker recipients, confirms the major contribution of conduction system disease to the SD of patients presenting with DM1, and supports the current recommendation for prophylactic pacing. In our study, major conduction defects were independently predicted by conduction defects on the ECG, or by a personal history of syncope or AF. In the study by Groh et al., the positive predictive value for SD of major conduction abnormalities on the ECG, defined as a PR interval > _240 ms or a QRS duration > _120 ms, was only 12%. 10 These observations highlight the limited ability of the ECG to predict the development of major conduction defects, and suggest that techniques such as invasive electrophysiological studies, should increase the accuracy of the risk stratification of patients suffering from DM1. 25, 26 In a previous study of over 900 patients with DM1, we found electrophysiological studies reliable in the identification high-risk patients, when conduction defects were present on the ECG, including 1st degree AV block or left and right BBB. 27 Prophylactic pacing in patients with a > _70-ms prolongation of the HV interval was associated with a 70% lower incidence of SD compared to follow-up without prophylactic pacing. 27 VTA were another major cause of SD in our patients, including young adults in the early stages of the disease. The causal role played by VTA was not surprising, since ventricular electrical instability has been previously identified as a manifestation of cardiac involvement in studies of DM1, though less frequently than conduction defects. 28 In a recent meta-analysis, non-sustained and sustained VT were respectively reported in 4.1 and 2.7% of patients suffering from DM1. 29 In our study, non-sustained VT was the only independent predictor of sustained VTA by multiple variable analysis. Furthermore, 12 of the 20 patients who developed a first episode of sustained VTA had a personal history of non-sustained VT, or other precipitating factors, such as severe LV systolic dysfunction or type 1 Brugada pattern on the ECG. We have previously shown that the type 1 Brugada pattern was 50-fold more prevalent in patients suffering from DM1 than in the general population and probably due to an abnormal splicing of SCN5A with sodium current dysfunction. [30] [31] [32] Our findings suggest that the implantation of ICD in DM1 should target patients with non-sustained or sustained VTA, severe LV dysfunction, or type 1 Brugada pattern. Non-cardiac causes of SD were detected in several patients, an observation concordant with the multiple clinical manifestations of DM1, such as swallowing difficulties, restrictive respiratory insufficiency, sleep apnoea, 33 and profound asthenia, which are potential causes of non-witnessed or nocturnal SD. In addition, several patients developed asystole with failure to capture by the pacing stimuli, which is consistent with a non-cardiac cause of SD. Complicating its prevention, the proportion of non-cardiac causes of SD is probably greater in DM1, which is characterized by the involvement of multiple systems, than in other inherited diseases that involve exclusively the heart, such as hypertrophic cardiomyopathy, or long QT syndrome. Therefore, preventive strategies in patients presenting with DM1 should focus on the long-term cardiac as well as non-cardiac management of the disease.
Limitations of our study
Our study may have overestimated the proportion of SD due to primary VTA in DM1 because the implantation of permanent pacemakers in nearly one third of our patients, compared with 10% in the study by Groh et al. 10 and 2.6% in the study by Breton et al., 24 may
have prevented a large number of SD due to major conduction system disease. The incidence of SD in these three studies was not the same because of dissimilar demographic characteristics and prevalence of baseline conduction defects among the samples. The causal implication of VTA in SD may be difficult to ascertain, including in recipients of cardiac devices, since VTA may be a by-product of cardiovascular collapse from another origin.
Supplementary material
Supplementary material is available at European Heart Journal online.
